Model to Predict Node Negative Disease After Neoadjuvant Chemotherapy Using Data from the National Cancer Data Base

被引：0
|
作者：
Murphy, B. L. [1 ]
Hoskin, T. [1 ]
Day, C. [1 ]
Habermann, E. B. [1 ]
Boughey, J. C. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PT36
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [21] No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base
    Al-Sukhni, Eisar
    Gabriel, Emmanuel
    Attwood, Kristopher
    Kukar, Moshim
    Nurkin, Steven J.
    Hochwald, Steven N.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (06) : 784 - +
  • [22] Ovarian cancer patients selected for neoadjuvant chemotherapy versus primary debulking surgery are not similar: A National Cancer Data Base study
    Leiserowitz, G. S.
    Lin, J. F.
    Tergas, A. I.
    Cliby, B. A.
    Bristow, R. E.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 40 - 41
  • [23] Analysis of the National Cancer Data Base (NCDB) on impact and trend of neoadjuvant chemotherapy in upper urinary tract urothelial cancer.
    Khan, Rashad
    Huang, Danning
    Basnet, Alina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [24] Use of Neoadjuvant Versus Adjuvant Chemotherapy for Hormone Receptor Positive Breast Cancer: A National Cancer Data Base (NCDB) Study
    Schmidt, H.
    Alberty-Oller, J.
    Zeidman, M.
    Ru, M.
    Pisapati, K.
    Moshier, E.
    Ahn, S.
    Mazumdar, M.
    Port, E.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S91 - S91
  • [25] Regional Nodal Irradiation in Breast Cancer Patients With Clinical N1 and Pathologic N0 Disease After Neoadjuvant Chemotherapy: An Analysis of the National Cancer Data Base
    Vu, C. C.
    Sura, K.
    Chen, P. Y.
    Dilworth, J. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E4 - E5
  • [26] Utilization, trend and impact of neoadjuvant endocrine therapy compared to neoadjuvant chemotherapy in postmenopausal breast cancer patients: Analysis of the National Cancer Data Base.
    Basnet, Alina
    Wang, Dongliang
    Sivapiragasam, Abirami
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Clinical Node Positive Disease is a High Predictor of Pathologically Positive Nodes: Report from the National Cancer Data Base
    Singh, Puneet
    Kuchta, Kristine
    Pesce, Catherine
    Winchester, David J.
    Barrera, Ermilo
    Yao, Katharine
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 167 - 168
  • [28] Ultrasound assessment of residual disease after neoadjuvant chemotherapy (NACT) in node positive triple negative breast cancer (TNBC)
    Adrada, B. E.
    Valero, V.
    Reddy, S. M.
    Barcenas, C. H.
    Candelaria, R.
    Wei, W.
    Rauch, G. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [29] Chemotherapy Trends for Triple Negative Metaplastic Versus Invasive Ductal Breast Cancer: A National Cancer Data Base Review
    Dinh, K. H.
    McAuliffe, P. F.
    Steiman, J. G.
    Soran, A.
    Keenan, D.
    Johnson, R.
    Diego, E. J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S101 - S101
  • [30] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V.
    Velasco, V.
    Pinard, C.
    Pellegrin, I.
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    Macgrogan, G.
    ANNALS OF ONCOLOGY, 2022, 33 : S127 - S127
12345